Elexacaftor-Tezacaftor-Ivacaftor Efficacious for Cystic Fibrosis
Percentage of FEV1 higher at four weeks and through 24 weeks with treatment versus placebo
Risk for Second Primary Malignancy Up in CLL Survivors
SPM risk higher for men and nonwhites, after chemotherapy, for recent years of diagnosis, for advanced age
Equivalence Seen Between Drug Classes for HTN Monotherapy
Thiazide, thiazide-like diuretics superior to ACEi; nondihydropyridine calcium channel blockers inferior
Borderline Personality Disorder May Raise Cardiometabolic Risk
Borderline personality traits, depression associated with extent of midlife cardiometabolic risk
Increase Seen in Opioid-, Synthetic Opioid-Involved OD Deaths
From 2015 to 2017, number of opioid-involved overdose deaths increased for nearly all racial/ethnic groups
October 2019 Briefing – Internal Medicine
Here are what the editors at HealthDay consider to be the most important developments in Internal Medicine for October 2019. This roundup includes the...
American Academy of Pediatrics, Oct. 25-29
The American Academy of Pediatrics National Conference and Exhibition The annual meeting of the American Academy of Pediatrics was held from Oct. 25...
U.S. Oncologist Shortage May Impact Women’s Health
Major U.S. cities are expected to have a shortage of oncologists
Recommendations Developed to Address Clinician Burnout
Six goals include creation of positive work and learning environments that prevent, reduce burnout
2007 to 2016 Saw Rise in ADHD Prevalence in Adults, Children
Increase seen for adults of every race/ethnicity; prevalence rates highest for white individuals
